Clinical features and treatment outcomes of pediatric acute promyelocytic leukemia in a Mexican pediatric hospital

Revista de Investigacion Clinica

Volumn 65, Issue 5, 2013, Pages 392-398

  Dorantes Acosta, Elisa ^a   Medina Sanson, Aurora ^a   Jaimes García, Yanet ^a   López Martínez, Briceida ^b  

^a HOSPITAL INFANTIL DE MÉXICO FEDERICO GÓMEZ   (Mexico)

^b Subdirección de Servicios Auxiliares y de Diagnóstico ^*  (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

6-MERCAPTOPURINE; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; CONSOLIDATION CHEMOTHERAPY; CYTARABINE; DAUNORUBICIN; DISSEMINATED INTRAVASCULAR COAGULATION; FEMALE; FOLLOW-UP STUDIES; HOSPITALS, PEDIATRIC; HUMANS; INFANT; KAPLAN-MEIER ESTIMATE; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; METHOTREXATE; MEXICO; MITOXANTRONE; ONCOGENE PROTEINS, FUSION; RECURRENCE; REMISSION INDUCTION; TREATMENT OUTCOME; TRETINOIN;

EID: 84894478996     PISSN: 00348376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Mantadakis E, Samonis G, Kalmanti M. A comprehensive review of acute promyelocytic leukemia in children. Acta Haematol 2008; 119: 73-82. (Pubitemid 351606165)
2. Dash A, Gilliland DG. Molecular genetics of acute myeloid leukaemia. Best Pract Res Clin Haematol 2001; 14: 49-64. (Pubitemid 32372401)
3. Masetti R, Vendemini F, Zama D, Biagi C, Gasperini P, Pession A. All-trans retinoic acid in the treatment of pediatric acute promyelocytic leukemia. Expert Rev Anticancer Ther 2012; 9: 1191-204.
4. Degos L, Wang ZW. All trans retinoic acid in acute promyelocytic leukemia. Oncogene 2001; 20: 7140-5. (Pubitemid 33107374)
5. Sanz MA, Montesinos P, Vellenga E, Rayón C, de la Serna J, Parody R, et al. Risk-adapted treatment of acute promyelocytic leukemia with all-trans retinoic acid and anthracycline monochemotherapy: long-term outcome of the LPA 99 multicenter study by the PETHEMA Group. Blood 2008; 112: 3130-4.
6. Rego EM, Jácomo RH. Epidemiology and treatment of acute promyelocytic leukemia in Latin America. Mediterr J Hematol Infect Dis 2011; 3(1): e2011049.
7. Ribeiro RC, Rego E. Management of APL in Developing Countries: Epidemiology, challenges and opportunities for international collaboration. Hematology Am Soc Hematol Educ Program 2006; 162-8.
8. da Costa Moraes CA, Trompieri NM, Cavalcante Felix FH. Pediatric acute promyelocytic leukemia: all-transretinoic acid therapy in a Brazilian pediatric hospital. J Pediatr Hematol Oncol 2008; 30: 387-90. (Pubitemid 351643464)
9. Rego EM, Kim HT, Ruiz-Argüelles GJ, Uriarte M del R, Jacomo RH, Gutiérrez-Aguirre H, Melo RA, et al. The impact of medical education and networking on the outcome of leukemia treatment in developing countries. The experience of International Consortium on Acute Promyelocytic Leukemia (ICAPL). Hematology 2012; S1: S36-S38.
10. Rubnitz JE, Gibson B, Smith FO. Acute myeloid leukemia. Pediatr Clin N Am 2008; 55: 21-51. (Pubitemid 351181320)
11. Jurcic JG. Monitoring PML-RARalpha in acute promyelocytic leukemia. Curr Oncol Rep 2003; 5: 391-8. (Pubitemid 38898808)
12. Cheson BD, Bennett JM, Kopecky KJ, Büchner T, Willman CL, Estey EH, et al. Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia. J Clin Oncol 2003; 24: 4642-9. (Pubitemid 46594039)
13. Sanz MA, Grimwade D, Tallman MS, Lowenberg B, Fenaux P, Estey EH, et al. Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European Leukemia Net. Blood 2009; 9: 1875-91.
14. Sanz MA, Montesinos P, Rayón C, Holowiecka A, de la Serna J, Milone G, et al., Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome. Blood 2010; 115: 5137-46.
15. Redner RL. Variations on a theme: the alternate translocations in APL. Leukemia 2002; 10: 1927-32. (Pubitemid 35203435)